Interferon-beta attenuates angiotensin II-accelerated atherosclerosis and vascular remodeling in apolipoprotein E deficient mice

Atherosclerosis

Volumn 197, Issue 1, 2008, Pages 204-211

  Zhang, Le Ning ^a   Velichko, Sharlene ^a   Vincelette, Jon ^a   Fitch, Richard M ^a   Vergona, Ronald ^a   Sullivan, Mark E ^a   Croze, Ed ^a   Wang, Yi Xin ^a  

^a BAYER AG   (Germany)

Author keywords

Abdominal aortic aneurysm; Angiotensin II; Atherosclerosis; Interferon beta; Intimal hyperplasia; Vascular remodeling

Indexed keywords

ANGIOTENSIN II; APOLIPOPROTEIN E; INTERFERON BETA SERINE;

ABDOMINAL AORTA ANEURYSM; ADVENTITIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA ARCH; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; COMMON CAROTID ARTERY; CONTROLLED STUDY; HEART VENTRICLE REMODELING; INTIMA; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SMOOTH MUSCLE FIBER;

ANGIOTENSIN II; ANIMALS; AORTA, THORACIC; AORTIC ANEURYSM, ABDOMINAL; APOLIPOPROTEINS E; ATHEROSCLEROSIS; CAROTID ARTERY, COMMON; CELL DIVISION; DRUG INTERACTIONS; FOAM CELLS; IMMUNOLOGIC FACTORS; INTERFERON-BETA; LIGATION; MALE; MICE; MICE, MUTANT STRAINS; TUNICA INTIMA; VASOCONSTRICTOR AGENTS;

EID: 39449112172     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atherosclerosis.2007.03.019     Document Type: Article

References (38)

1. Libby P. Inflammation in atherosclerosis. Nature 420 (2002) 868-874
2. Wang Y.X., Martin-McNulty B., Freay A.D., et al. Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice. Am J Pathol 159 (2001) 1455-1464
3. Deng G.G., Martin-McNulty B., Sukovich D.A., et al. Urokinase-type plasminogen activator plays a critical role in angiotensin II-induced abdominal aortic aneurysm. Circ Res 92 (2003) 510-517
4. Daugherty A., Manning M.W., and Cassis L.A. Angiotensin II promotes atherosclerotic lesions and aneurysms in apolipoprotein E-deficient mice. J Clin Invest 105 (2000) 1605-1612
5. Zhang L.N., Wilson D.W., da Cunha V., et al. NO synthase deficiency promotes smooth muscle progenitor cells in association with upregulation of stromal cell-derived factor-1alpha in a mouse model of carotid artery ligation. Arterioscler Thromb Vasc Biol 26 (2006) 765-772
6. Zhang L.N., da Cunha V., Martin-McNulty B., et al. Endothelial nitric oxide synthase deficiency enhanced carotid artery ligation-Induced remodeling by promoting vascular inflammation. J Appl Res 6 (2006) 100-114
7. da Cunha V., Martin-McNulty B., Vincelette J., et al. Interaction between mild hypercholesterolemia, HDL-cholesterol levels, and angiotensin II in intimal hyperplasia in mice. J Lipid Res 47 (2006) 476-483
8. da Cunha V., Martin-McNulty B., Vincelette J., et al. Angiotensin II induces histomorphologic feature of unstable plaque in a murine model of accelerated atherosclerosis. J Vasc Surg 44 (2006) 364-371
9. Billiau A., Kieseier B.C., and Hartung H.P. Biologic role of interferon beta in multiple sclerosis. J Neurol 251 Suppl. 2 (2004) II10-II14
10. Tham D.M., Martin-McNulty B., Wang Y.X., et al. Angiotensin II is associated with activation of NF-kappaB-mediated genes and downregulation of PPARs. Physiol Genomics 11 (2002) 21-30
11. Martin-McNulty B., Tham D.M., da Cunha V., et al. 17 Beta-estradiol attenuates development of angiotensin II-induced aortic abdominal aneurysm in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol 23 (2003) 1627-1632
12. Isaacs A., and Lindenmann J. Virus interference. I. The interferon. By A. Isaacs and J. Lindenmann, 1957. J Interferon Res 7 (1987) 429-438
13. Hepatitis Interventional Therapy Group. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. N Engl J Med 339 (1998) 1485-1492
14. Tsao H., Atkins M.B., and Sober A.J. Management of cutaneous melanoma. N Engl J Med 351 (2004) 998-1012
15. CHAMPS Study Group. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 343 (2000) 898-904
16. Wessely R. Interference by interferons: Janus faces in vascular proliferative diseases. Cardiovasc Res 66 (2005) 433-443
17. Palmer H., and Libby P. Interferon-beta. A potential autocrine regulator of human vascular smooth muscle cell growth. Lab Invest 66 (1992) 715-721
18. Mintzer R.J., Croze E., Rubanyi G.M., and Johns A. Differential effects of IFN-beta1b on the proliferation of human vascular smooth muscle and endothelial cells. J Interferon Cytokine Res 18 (1998) 939-945
19. Stephan D., San H., Yang Z.Y., et al. Inhibition of vascular smooth muscle cell proliferation and intimal hyperplasia by gene transfer of beta-interferon. Mol Med 3 (1997) 593-599
20. Wilson A.C., Schaub R.G., Goldstein R.C., and Kuo P.T. Suppression of aortic atherosclerosis in cholesterol-fed rabbits by purified rabbit interferon. Arteriosclerosis 10 (1990) 208-214
21. Bruemmer D., Collins A.R., Noh G., et al. Angiotensin II-accelerated atherosclerosis and aneurysm formation is attenuated in osteopontin-deficient mice. J Clin Invest 112 (2003) 1318-1331
22. Jacoby D.S., and Rader D.J. Renin-angiotensin system and atherothrombotic disease: from genes to treatment. Arch Intern Med 163 (2003) 1155-1164
23. Nobuhiko A., Suganuma E., Babaev V.R., et al. Angiotensin II amplifies macrophage-driven atherosclerosis. Arterioscler Thromb Vasc Biol 24 (2004) 2143-2148
24. Rieckmann P., Kruse N., Nagelkerken L., et al. Soluble vascular cell adhesion molecule (VCAM) is associated with treatment effects of interferon beta-1b in patients with secondary progressive multiple sclerosis. J Neurol 252 (2005) 526-533
25. Veldhuis W.B., Floris S., van der Meide P.H., et al. Interferon-beta prevents cytokine-induced neutrophil infiltration and attenuates blood-brain barrier disruption. J Cereb Blood Flow Metab 23 (2003) 1060-1069
26. Zang Y.C., Halder J.B., Samanta A.K., Hong J., Rivera V.M., and Zhang J.Z. Regulation of chemokine receptor CCR5 and production of RANTES and MIP-1alpha by interferon-beta. J Neuroimmunol 112 (2001) 174-180
27. Lou J., Gasche Y., Zheng L., et al. Interferon-beta inhibits activated leukocyte migration through human brain microvascular endothelial cell monolayer. Lab Invest 79 (1999) 1015-1025
28. Van Weyenbergh J., Wietzerbin J., Rouillard D., Barral-Netto M., and Liblau R. Treatment of multiple sclerosis patients with interferon-beta primes monocyte-derived macrophages for apoptotic cell death. J Leukoc Biol 70 (2001) 745-748
29. Sharief M.K., Semra Y.K., Seidi O.A., and Zoukos Y. Interferon-beta therapy downregulates the anti-apoptosis protein FLIP in T cells from patients with multiple sclerosis. J Neuroimmunol 120 (2001) 199-207
30. Landmesser U., Hornig B., and Drexler H. Endothelial function: a critical determinant in atherosclerosis?. Circulation 109 (2004) II27-II33
31. Kumar A., Hoover J.L., Simmons C.A., Lindner V., and Shebuski R.J. Remodeling and neointimal formation in the carotid artery of normal and P-selectin-deficient mice. Circulation 96 (1997) 4333-4342
32. Ross R. Atherosclerosis is an inflammatory disease. Am Heart J 138 (1999) S419-S420
33. Daugherty A., and Cassis L.A. Mechanisms of abdominal aortic aneurysm formation. Curr Atheroscler Rep 4 (2002) 222-227
34. Prescott M.F., Sawyer W.K., Von Linden-Reed J., et al. Effect of matrix metalloproteinase inhibition on progression of atherosclerosis and aneurysm in LDL receptor-deficient mice overexpressing MMP-3, MMP-12, and MMP-13 and on restenosis in rats after balloon injury. Ann NY Acad Sci 878 (1999) 179-190
35. Wang Y.X., Martin-McNulty B., da Cunha V., et al. Fasudil, a Rho-kinase inhibitor, attenuates angiotensin II-induced abdominal aortic aneurysm in apolipoprotein E-deficient mice by inhibiting apoptosis and proteolysis. Circulation 111 (2005) 2219-2226
36. da Cunha V., Tham D.M., Martin-McNulty B., et al. Enalapril attenuates angiotensin II-induced atherosclerosis and vascular inflammation. Atherosclerosis 178 (2005) 9-17
37. Golledge J., Muller J., Daugherty A., and Norman P. Abdominal Aortic Aneurysm. Pathogenesis and implications for management. Arterioscler Thromb Vasc Biol (2006)
38. Shimizu K., Mitchell R.N., and Libby P. Inflammation and cellular immune responses in abdominal aortic aneurysms. Arterioscler Thromb Vasc Biol 26 (2006) 987-994